Adamdec1, Ednrb and Ptgs1/Cox1, inflammation genes upregulated in the intestinal mucosa of obese rats, are downregulated by three probiotic strains

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Plaza Diáz, Julio ^a,b   Robles Sánchez, Cándido ^a,b   Abadiá Molina, Francisco ^a   Morón Calvente, Virginia ^a   Saéz Lara, Mariá José ^a   Ruiz Bravo, Alfonso ^a   Jiménez Valera, Mariá ^a   Gil, Ángel ^a,b,c   Gómez Llorente, Carolina ^a,b,c   Fontana, Luis ^a,b  

^a UNIVERSITY OF GRANADA   (Spain)

^b Instituto de Investigación Biosanitaria ibs   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; CYCLOOXYGENASE 1; DECYSIN; EDNRB PROTEIN, RAT; ENDOTHELIN B RECEPTOR; MEMBRANE PROTEIN; PROBIOTIC AGENT; PTGS1 PROTEIN, RAT;

ANIMAL; DENDRITIC CELL; ENTERITIS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INTESTINE FLORA; INTESTINE MUCOSA; MACROPHAGE; METABOLISM; OBESITY; PATHOLOGY; PHENOTYPE; RAT; ZUCKER RAT;

ADAM PROTEINS; ANIMALS; CYCLOOXYGENASE 1; DENDRITIC CELLS; ENTERITIS; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION; INTESTINAL MUCOSA; MACROPHAGES; MEMBRANE PROTEINS; OBESITY; PHENOTYPE; PROBIOTICS; RATS; RATS, ZUCKER; RECEPTOR, ENDOTHELIN B;

EID: 85019445512     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-02203-3     Document Type: Article

References (25)

1. Reaven, G. M. Role of insulin resistance in human disease. Diabetes 37, 1595-1607, doi:10.2337/diab.37.12.1595 (1988).
2. Reaven, G. M. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, different goals. Endocrinol Metab Clin North Am 33, 283-303, doi:10.1016/j.ecl.2004.03.002 (2004).
3. Lakka, H. M., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288, 2709-2716, doi:10.1001/jama.288.21.2709 (2002).
4. Kahn, R., et al. The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28, 2289-2304, doi:10.2337/diacare.28.9.2289 (2005).
5. Plaza-Diáz, J., et al. Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker Rats. PLOS ONE 9, e98401, doi:10.1371/journal.pone.0098401 (2014).
6. Guarner, F., Schaafsma, G. J. Probiotics. Int J Food Microbiol 39, 237-238, doi:10.1016/S0168-1605(97)00136-0 (1998).
7. Fontana, L., Bermudez-Brito, M., Plaza-Diaz, J., Munõz-Quezada, S., Gil, A. Sources, isolation, characterisation and evaluation of probiotics. Br J Nutr 109, S35-50, doi:10.1017/S0007114512004011 (2013).
8. Bermúdez-Brito, M., Plaza-Diáz, J., Munõz-Quezada, S., Gómez-Llorente, C., Gil, A. Probiotic mechanism of action. Ann Nutr Metab 61, 160-174, doi:10.1159/000342079 (2012).
9. Dykstra, N., et al. Pulse probiotic administration induces repeated small intestinal Muc3 expression in rats. Pediatr Res 69, 206-211, doi:10.1203/PDR.0b013e3182096ff0 (2011).
10. Ohtsuka, Y., et al. Effects of Bifidobacterium breve on inflammatory gene expression in neonatal and weaning rat intestine. Pediatr Res 71, 46-53, doi:10.1038/pr.2011.11 (2012).
11. Plaza-Diáz, J., et al. Safety and immunomodulatory effects of three probiotic strains isolated from the feces of breast-fed infants in healthy adults: SETOPROB study. PLOS ONE 8, e78111, doi:10.1371/journal.pone.0078111 (2013).
12. Munõz-Quezada, S., et al. Isolation, identification and characterisation of three novel probiotic strains (Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036) from the faeces of exclusively breast-fed infants. Br J Nutr 109, S51-S62, doi:10.1017/S0007114512005211 (2013).
13. O'Shea, N. R., et al. Critical Role of the Disintegrin Metalloprotease ADAM-like Decysin-1 [ADAMDEC1] for Intestinal Immunity and Inflammation. J Crohns Colitis 10, 1417-1427, doi:10.1093/ecco-jcc/jjw111 (2016).
14. Zarpelon, A. C., et al. Endothelin-1 induces neutrophil recruitment in adaptive inflammation via TNF-? and CXCL1/CXCR2 in mice. Can J Physiol Pharmacol 90, 187-199, doi:10.1139/y11-116 (2012).
15. Yildiz, H. M., Carlson, T. L., Goldstein, A. M., Carrier, R. L. Mucus barriers to microparticles and microbes are altered in Hirschprung's disease. Macromol Biosci 15, 712-718, doi:10.1002/mabi.201400473 (2015).
16. Saraswathi, V., et al. Impact of hematopoietic cyclooxygenase-1 deficiency on obesity-linked adipose tissue inflammation and metabolic disorders in mice. Metabolism 62, 1673-1685, doi:10.1016/j.metabol.2013.07.007 (2013).
17. Plaza-Diáz, J., et al. Pyrosequencing analysis reveals changes in intestinal microbiota of healthy adults who received a daily dose of immunomodulatory probiotic strains. Nutrients 7, 3999-4015, doi:10.3390/nu7063999 (2015).
18. Brahe, L. K., Astrup, A., Larsen, L. H. Can we prevent obesity-related metabolic diseases by dietary modulation of the gut microbiota? Adv Nutr 7, 90-101, doi:10.3945/an.115.010587 (2016).
19. Wang, J., et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J 9, 1-15, doi:10.1038/ismej.2014.99 (2015).
20. Kemgang, T. S., Kapila, S., Shanmugam, V. P., Reddi, S., Kapila, R. Fermented milk with probiotic Lactobacillus rhamnosus S1K3 (MTCC5957) protects mice from Salmonella by enhancing immune and nonimmune protection mechanisms at intestinal mucosal level. J Nutr Biochem 30, 62-73, doi:10.1016/j.jnutbio.2015.11.018 (2016).
21. Tannock, G. W., et al. Altered transcription of murine genes induced in the small bowel by administration of probiotic strain Lactobacillus rhamnosus HN001. Appl Environ Microbiol 80, 2851-2859, doi:10.1128/AEM.00336-14 (2014).
22. Balakumar, M., et al. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. Eur J Nutr 10.1007/s00394-016-1317-7 (2016).
23. Wang, H., Jatmiko, Y. D., Bastian, S. E., Mashtoub, S., Howarth, G. S. Effects of supernatants from Escherichia coli Nissle 1917 and Faecalibacterium prausnitzii on intestinal epithelial cells and a rat model of 5-fluorouracil-induced mucositis. Nutr Cancer 69, 307-318, doi:10.1080/01635581.2017.1263747 (2017).
24. Tian, P., et al. Antidiabetic (type 2) effects of Lactobacillus G15 and Q14 in rats through regulation of intestinal permeability and microbiota. Food Funct 7, 3789-3797, doi:10.1039/c6fo00831c (2016).
25. Cani, P. D., Van Hul, M. Novel opportunities for next-generation probiotics targeting metabolic syndrome. Curr Opin Biotechnol 32, 21-27, doi:10.1016/j.copbio.2014.10.006 (2015).